nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—obesity—type 2 diabetes mellitus	0.545	1	CtDrD
Topiramate—CYP3A4—type 2 diabetes mellitus	0.0619	1	CbGaD
Topiramate—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0163	0.108	CbGbCtD
Topiramate—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0139	0.0918	CbGbCtD
Topiramate—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0139	0.0918	CbGbCtD
Topiramate—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0128	0.0847	CbGbCtD
Topiramate—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0124	0.0818	CbGbCtD
Topiramate—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0104	0.0689	CbGbCtD
Topiramate—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00927	0.0614	CbGbCtD
Topiramate—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00848	0.0561	CbGbCtD
Topiramate—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00741	0.0491	CbGbCtD
Topiramate—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00709	0.047	CbGbCtD
Topiramate—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0067	0.0444	CbGbCtD
Topiramate—CYP2C19—Losartan—type 2 diabetes mellitus	0.00649	0.043	CbGbCtD
Topiramate—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00508	0.0336	CbGbCtD
Topiramate—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00487	0.0322	CbGbCtD
Topiramate—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00487	0.0322	CbGbCtD
Topiramate—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0046	0.0305	CbGbCtD
Topiramate—GRIK1—peripheral nervous system—type 2 diabetes mellitus	0.00431	0.115	CbGeAlD
Topiramate—GRIA4—nerve—type 2 diabetes mellitus	0.00383	0.102	CbGeAlD
Topiramate—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00343	0.0227	CbGbCtD
Topiramate—GRIK1—nerve—type 2 diabetes mellitus	0.00336	0.0898	CbGeAlD
Topiramate—CYP3A4—Losartan—type 2 diabetes mellitus	0.00314	0.0208	CbGbCtD
Topiramate—GRIA3—nerve—type 2 diabetes mellitus	0.00312	0.0835	CbGeAlD
Topiramate—GRIA1—nerve—type 2 diabetes mellitus	0.00167	0.0446	CbGeAlD
Topiramate—GRIK4—kidney—type 2 diabetes mellitus	0.00166	0.0444	CbGeAlD
Topiramate—GRIA4—retina—type 2 diabetes mellitus	0.00159	0.0424	CbGeAlD
Topiramate—GRIK3—retina—type 2 diabetes mellitus	0.00146	0.0391	CbGeAlD
Topiramate—GRIK1—retina—type 2 diabetes mellitus	0.00139	0.0372	CbGeAlD
Topiramate—GRIK2—nerve—type 2 diabetes mellitus	0.0012	0.032	CbGeAlD
Topiramate—GRIK5—cortex of kidney—type 2 diabetes mellitus	0.00118	0.0315	CbGeAlD
Topiramate—CA1—nerve—type 2 diabetes mellitus	0.000886	0.0237	CbGeAlD
Topiramate—CA9—islet of Langerhans—type 2 diabetes mellitus	0.000732	0.0196	CbGeAlD
Topiramate—CA4—nerve—type 2 diabetes mellitus	0.000693	0.0185	CbGeAlD
Topiramate—GRIA1—retina—type 2 diabetes mellitus	0.000691	0.0185	CbGeAlD
Topiramate—GRIA3—liver—type 2 diabetes mellitus	0.000677	0.0181	CbGeAlD
Topiramate—CA7—kidney—type 2 diabetes mellitus	0.00059	0.0158	CbGeAlD
Topiramate—CA5A—liver—type 2 diabetes mellitus	0.000561	0.015	CbGeAlD
Topiramate—GRIA1—adipose tissue—type 2 diabetes mellitus	0.000515	0.0138	CbGeAlD
Topiramate—GRIK2—retina—type 2 diabetes mellitus	0.000496	0.0132	CbGeAlD
Topiramate—CA12—kidney—type 2 diabetes mellitus	0.000383	0.0102	CbGeAlD
Topiramate—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000352	0.00939	CbGeAlD
Topiramate—CA5B—pancreas—type 2 diabetes mellitus	0.000342	0.00913	CbGeAlD
Topiramate—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000341	0.0091	CbGeAlD
Topiramate—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000335	0.00896	CbGeAlD
Topiramate—CA1—cardiovascular system—type 2 diabetes mellitus	0.00031	0.00829	CbGeAlD
Topiramate—CA5B—adipose tissue—type 2 diabetes mellitus	0.00031	0.00828	CbGeAlD
Topiramate—CA1—kidney—type 2 diabetes mellitus	0.000304	0.00812	CbGeAlD
Topiramate—CA1—pancreas—type 2 diabetes mellitus	0.000302	0.00806	CbGeAlD
Topiramate—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000278	0.00743	CbGeAlD
Topiramate—CA1—adipose tissue—type 2 diabetes mellitus	0.000274	0.00731	CbGeAlD
Topiramate—CA4—nephron tubule—type 2 diabetes mellitus	0.00027	0.00722	CbGeAlD
Topiramate—CA4—cardiovascular system—type 2 diabetes mellitus	0.000243	0.00648	CbGeAlD
Topiramate—CA2—retina—type 2 diabetes mellitus	0.000238	0.00635	CbGeAlD
Topiramate—CA4—kidney—type 2 diabetes mellitus	0.000237	0.00634	CbGeAlD
Topiramate—CA4—cortex of kidney—type 2 diabetes mellitus	0.000231	0.00618	CbGeAlD
Topiramate—CA2—nephron tubule—type 2 diabetes mellitus	0.000224	0.00598	CbGeAlD
Topiramate—CA4—adipose tissue—type 2 diabetes mellitus	0.000214	0.00572	CbGeAlD
Topiramate—CA2—cardiovascular system—type 2 diabetes mellitus	0.000201	0.00538	CbGeAlD
Topiramate—CA2—kidney—type 2 diabetes mellitus	0.000197	0.00526	CbGeAlD
Topiramate—CA2—pancreas—type 2 diabetes mellitus	0.000196	0.00522	CbGeAlD
Topiramate—CA1—liver—type 2 diabetes mellitus	0.000192	0.00513	CbGeAlD
Topiramate—CA2—cortex of kidney—type 2 diabetes mellitus	0.000192	0.00512	CbGeAlD
Topiramate—CA2—adipose tissue—type 2 diabetes mellitus	0.000177	0.00474	CbGeAlD
Topiramate—CYP2C19—liver—type 2 diabetes mellitus	0.000136	0.00363	CbGeAlD
Topiramate—CYP3A4—kidney—type 2 diabetes mellitus	0.000127	0.00339	CbGeAlD
Topiramate—CA2—liver—type 2 diabetes mellitus	0.000124	0.00332	CbGeAlD
Topiramate—CYP3A4—liver—type 2 diabetes mellitus	8.03e-05	0.00214	CbGeAlD
Topiramate—Malaise—Losartan—type 2 diabetes mellitus	3.4e-05	0.000253	CcSEcCtD
Topiramate—Anxiety—Irbesartan—type 2 diabetes mellitus	3.4e-05	0.000253	CcSEcCtD
Topiramate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	3.4e-05	0.000253	CcSEcCtD
Topiramate—Nervous system disorder—Metformin—type 2 diabetes mellitus	3.4e-05	0.000253	CcSEcCtD
Topiramate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.39e-05	0.000253	CcSEcCtD
Topiramate—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.39e-05	0.000253	CcSEcCtD
Topiramate—Vertigo—Losartan—type 2 diabetes mellitus	3.39e-05	0.000252	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.000252	CcSEcCtD
Topiramate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.39e-05	0.000252	CcSEcCtD
Topiramate—Somnolence—Valsartan—type 2 diabetes mellitus	3.38e-05	0.000252	CcSEcCtD
Topiramate—Syncope—Losartan—type 2 diabetes mellitus	3.38e-05	0.000252	CcSEcCtD
Topiramate—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000251	CcSEcCtD
Topiramate—Leukopenia—Losartan—type 2 diabetes mellitus	3.38e-05	0.000251	CcSEcCtD
Topiramate—Discomfort—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000251	CcSEcCtD
Topiramate—Skin disorder—Metformin—type 2 diabetes mellitus	3.37e-05	0.000251	CcSEcCtD
Topiramate—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.36e-05	0.00025	CcSEcCtD
Topiramate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.35e-05	0.000249	CcSEcCtD
Topiramate—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.35e-05	0.000249	CcSEcCtD
Topiramate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000249	CcSEcCtD
Topiramate—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.34e-05	0.000248	CcSEcCtD
Topiramate—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.34e-05	0.000248	CcSEcCtD
Topiramate—Palpitations—Losartan—type 2 diabetes mellitus	3.33e-05	0.000248	CcSEcCtD
Topiramate—Nausea—Glimepiride—type 2 diabetes mellitus	3.32e-05	0.000247	CcSEcCtD
Topiramate—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.32e-05	0.000247	CcSEcCtD
Topiramate—Nausea—Sitagliptin—type 2 diabetes mellitus	3.31e-05	0.000246	CcSEcCtD
Topiramate—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.31e-05	0.000246	CcSEcCtD
Topiramate—Asthenia—Glyburide—type 2 diabetes mellitus	3.31e-05	0.000246	CcSEcCtD
Topiramate—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000246	CcSEcCtD
Topiramate—Anorexia—Metformin—type 2 diabetes mellitus	3.3e-05	0.000246	CcSEcCtD
Topiramate—Cough—Losartan—type 2 diabetes mellitus	3.29e-05	0.000245	CcSEcCtD
Topiramate—Urticaria—Gliclazide—type 2 diabetes mellitus	3.29e-05	0.000245	CcSEcCtD
Topiramate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.29e-05	0.000245	CcSEcCtD
Topiramate—Alopecia—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000244	CcSEcCtD
Topiramate—Fatigue—Valsartan—type 2 diabetes mellitus	3.28e-05	0.000244	CcSEcCtD
Topiramate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.28e-05	0.000244	CcSEcCtD
Topiramate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.28e-05	0.000244	CcSEcCtD
Topiramate—Oedema—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000243	CcSEcCtD
Topiramate—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.27e-05	0.000243	CcSEcCtD
Topiramate—Pruritus—Glyburide—type 2 diabetes mellitus	3.26e-05	0.000243	CcSEcCtD
Topiramate—Mental disorder—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000242	CcSEcCtD
Topiramate—Constipation—Valsartan—type 2 diabetes mellitus	3.26e-05	0.000242	CcSEcCtD
Topiramate—Infection—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000242	CcSEcCtD
Topiramate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000242	CcSEcCtD
Topiramate—Fatigue—Orlistat—type 2 diabetes mellitus	3.24e-05	0.000241	CcSEcCtD
Topiramate—Hypotension—Metformin—type 2 diabetes mellitus	3.24e-05	0.000241	CcSEcCtD
Topiramate—Erythema—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000241	CcSEcCtD
Topiramate—Malnutrition—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000241	CcSEcCtD
Topiramate—Shock—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000239	CcSEcCtD
Topiramate—Pain—Orlistat—type 2 diabetes mellitus	3.22e-05	0.000239	CcSEcCtD
Topiramate—Chest pain—Losartan—type 2 diabetes mellitus	3.21e-05	0.000239	CcSEcCtD
Topiramate—Myalgia—Losartan—type 2 diabetes mellitus	3.21e-05	0.000239	CcSEcCtD
Topiramate—Arthralgia—Losartan—type 2 diabetes mellitus	3.21e-05	0.000239	CcSEcCtD
Topiramate—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.21e-05	0.000239	CcSEcCtD
Topiramate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000239	CcSEcCtD
Topiramate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000238	CcSEcCtD
Topiramate—Anxiety—Losartan—type 2 diabetes mellitus	3.2e-05	0.000238	CcSEcCtD
Topiramate—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000238	CcSEcCtD
Topiramate—Rash—Bromocriptine—type 2 diabetes mellitus	3.18e-05	0.000237	CcSEcCtD
Topiramate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.18e-05	0.000237	CcSEcCtD
Topiramate—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000236	CcSEcCtD
Topiramate—Tension—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000236	CcSEcCtD
Topiramate—Discomfort—Losartan—type 2 diabetes mellitus	3.17e-05	0.000236	CcSEcCtD
Topiramate—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000236	CcSEcCtD
Topiramate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.16e-05	0.000235	CcSEcCtD
Topiramate—Headache—Bromocriptine—type 2 diabetes mellitus	3.16e-05	0.000235	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.16e-05	0.000235	CcSEcCtD
Topiramate—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.16e-05	0.000235	CcSEcCtD
Topiramate—Nervousness—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000234	CcSEcCtD
Topiramate—Dry mouth—Losartan—type 2 diabetes mellitus	3.14e-05	0.000234	CcSEcCtD
Topiramate—Anorexia—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000232	CcSEcCtD
Topiramate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.11e-05	0.000232	CcSEcCtD
Topiramate—Paraesthesia—Metformin—type 2 diabetes mellitus	3.11e-05	0.000232	CcSEcCtD
Topiramate—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000231	CcSEcCtD
Topiramate—Confusional state—Losartan—type 2 diabetes mellitus	3.1e-05	0.000231	CcSEcCtD
Topiramate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.1e-05	0.000231	CcSEcCtD
Topiramate—Dyspnoea—Metformin—type 2 diabetes mellitus	3.09e-05	0.00023	CcSEcCtD
Topiramate—Somnolence—Metformin—type 2 diabetes mellitus	3.08e-05	0.000229	CcSEcCtD
Topiramate—Oedema—Losartan—type 2 diabetes mellitus	3.08e-05	0.000229	CcSEcCtD
Topiramate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.08e-05	0.000229	CcSEcCtD
Topiramate—Infection—Losartan—type 2 diabetes mellitus	3.06e-05	0.000228	CcSEcCtD
Topiramate—Hypotension—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000227	CcSEcCtD
Topiramate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.05e-05	0.000227	CcSEcCtD
Topiramate—Dyspepsia—Metformin—type 2 diabetes mellitus	3.05e-05	0.000227	CcSEcCtD
Topiramate—Tremor—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000225	CcSEcCtD
Topiramate—Shock—Losartan—type 2 diabetes mellitus	3.03e-05	0.000225	CcSEcCtD
Topiramate—Urticaria—Valsartan—type 2 diabetes mellitus	3.02e-05	0.000225	CcSEcCtD
Topiramate—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.02e-05	0.000225	CcSEcCtD
Topiramate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.01e-05	0.000224	CcSEcCtD
Topiramate—Decreased appetite—Metformin—type 2 diabetes mellitus	3.01e-05	0.000224	CcSEcCtD
Topiramate—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.01e-05	0.000224	CcSEcCtD
Topiramate—Tachycardia—Losartan—type 2 diabetes mellitus	3.01e-05	0.000224	CcSEcCtD
Topiramate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3e-05	0.000223	CcSEcCtD
Topiramate—Nausea—Bromocriptine—type 2 diabetes mellitus	3e-05	0.000223	CcSEcCtD
Topiramate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.99e-05	0.000223	CcSEcCtD
Topiramate—Fatigue—Metformin—type 2 diabetes mellitus	2.99e-05	0.000222	CcSEcCtD
Topiramate—Urticaria—Orlistat—type 2 diabetes mellitus	2.99e-05	0.000222	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000222	CcSEcCtD
Topiramate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.98e-05	0.000221	CcSEcCtD
Topiramate—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.97e-05	0.000221	CcSEcCtD
Topiramate—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.97e-05	0.000221	CcSEcCtD
Topiramate—Asthenia—Gliclazide—type 2 diabetes mellitus	2.97e-05	0.000221	CcSEcCtD
Topiramate—Agitation—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000221	CcSEcCtD
Topiramate—Constipation—Metformin—type 2 diabetes mellitus	2.96e-05	0.000221	CcSEcCtD
Topiramate—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000219	CcSEcCtD
Topiramate—Anorexia—Losartan—type 2 diabetes mellitus	2.93e-05	0.000218	CcSEcCtD
Topiramate—Vomiting—Glyburide—type 2 diabetes mellitus	2.93e-05	0.000218	CcSEcCtD
Topiramate—Pruritus—Gliclazide—type 2 diabetes mellitus	2.93e-05	0.000218	CcSEcCtD
Topiramate—Malaise—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000217	CcSEcCtD
Topiramate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000217	CcSEcCtD
Topiramate—Rash—Glyburide—type 2 diabetes mellitus	2.91e-05	0.000216	CcSEcCtD
Topiramate—Somnolence—Irbesartan—type 2 diabetes mellitus	2.91e-05	0.000216	CcSEcCtD
Topiramate—Dermatitis—Glyburide—type 2 diabetes mellitus	2.91e-05	0.000216	CcSEcCtD
Topiramate—Vertigo—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000216	CcSEcCtD
Topiramate—Syncope—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000216	CcSEcCtD
Topiramate—Leukopenia—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000215	CcSEcCtD
Topiramate—Headache—Glyburide—type 2 diabetes mellitus	2.89e-05	0.000215	CcSEcCtD
Topiramate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000214	CcSEcCtD
Topiramate—Hypotension—Losartan—type 2 diabetes mellitus	2.88e-05	0.000214	CcSEcCtD
Topiramate—Palpitations—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000213	CcSEcCtD
Topiramate—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.86e-05	0.000213	CcSEcCtD
Topiramate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000212	CcSEcCtD
Topiramate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000212	CcSEcCtD
Topiramate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.84e-05	0.000211	CcSEcCtD
Topiramate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.83e-05	0.000211	CcSEcCtD
Topiramate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.00021	CcSEcCtD
Topiramate—Cough—Ramipril—type 2 diabetes mellitus	2.82e-05	0.00021	CcSEcCtD
Topiramate—Fatigue—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.00021	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.81e-05	0.000209	CcSEcCtD
Topiramate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.8e-05	0.000209	CcSEcCtD
Topiramate—Convulsion—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000209	CcSEcCtD
Topiramate—Constipation—Irbesartan—type 2 diabetes mellitus	2.8e-05	0.000208	CcSEcCtD
Topiramate—Pain—Irbesartan—type 2 diabetes mellitus	2.8e-05	0.000208	CcSEcCtD
Topiramate—Insomnia—Losartan—type 2 diabetes mellitus	2.78e-05	0.000207	CcSEcCtD
Topiramate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.77e-05	0.000206	CcSEcCtD
Topiramate—Paraesthesia—Losartan—type 2 diabetes mellitus	2.76e-05	0.000206	CcSEcCtD
Topiramate—Urticaria—Metformin—type 2 diabetes mellitus	2.75e-05	0.000205	CcSEcCtD
Topiramate—Chest pain—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000205	CcSEcCtD
Topiramate—Arthralgia—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000205	CcSEcCtD
Topiramate—Myalgia—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000205	CcSEcCtD
Topiramate—Dyspnoea—Losartan—type 2 diabetes mellitus	2.75e-05	0.000204	CcSEcCtD
Topiramate—Anxiety—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000204	CcSEcCtD
Topiramate—Nausea—Glyburide—type 2 diabetes mellitus	2.74e-05	0.000204	CcSEcCtD
Topiramate—Abdominal pain—Metformin—type 2 diabetes mellitus	2.74e-05	0.000204	CcSEcCtD
Topiramate—Dizziness—Gliclazide—type 2 diabetes mellitus	2.74e-05	0.000204	CcSEcCtD
Topiramate—Somnolence—Losartan—type 2 diabetes mellitus	2.74e-05	0.000204	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000203	CcSEcCtD
Topiramate—Asthenia—Valsartan—type 2 diabetes mellitus	2.73e-05	0.000203	CcSEcCtD
Topiramate—Discomfort—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000202	CcSEcCtD
Topiramate—Dyspepsia—Losartan—type 2 diabetes mellitus	2.71e-05	0.000202	CcSEcCtD
Topiramate—Asthenia—Orlistat—type 2 diabetes mellitus	2.7e-05	0.000201	CcSEcCtD
Topiramate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000201	CcSEcCtD
Topiramate—Pruritus—Valsartan—type 2 diabetes mellitus	2.69e-05	0.0002	CcSEcCtD
Topiramate—Dry mouth—Ramipril—type 2 diabetes mellitus	2.69e-05	0.0002	CcSEcCtD
Topiramate—Decreased appetite—Losartan—type 2 diabetes mellitus	2.68e-05	0.000199	CcSEcCtD
Topiramate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.000199	CcSEcCtD
Topiramate—Confusional state—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000198	CcSEcCtD
Topiramate—Pruritus—Orlistat—type 2 diabetes mellitus	2.66e-05	0.000198	CcSEcCtD
Topiramate—Fatigue—Losartan—type 2 diabetes mellitus	2.65e-05	0.000197	CcSEcCtD
Topiramate—Oedema—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000196	CcSEcCtD
Topiramate—Vomiting—Gliclazide—type 2 diabetes mellitus	2.63e-05	0.000196	CcSEcCtD
Topiramate—Constipation—Losartan—type 2 diabetes mellitus	2.63e-05	0.000196	CcSEcCtD
Topiramate—Pain—Losartan—type 2 diabetes mellitus	2.63e-05	0.000196	CcSEcCtD
Topiramate—Rash—Gliclazide—type 2 diabetes mellitus	2.61e-05	0.000194	CcSEcCtD
Topiramate—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.61e-05	0.000194	CcSEcCtD
Topiramate—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.6e-05	0.000194	CcSEcCtD
Topiramate—Urticaria—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000193	CcSEcCtD
Topiramate—Shock—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000193	CcSEcCtD
Topiramate—Headache—Gliclazide—type 2 diabetes mellitus	2.6e-05	0.000193	CcSEcCtD
Topiramate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000193	CcSEcCtD
Topiramate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.000192	CcSEcCtD
Topiramate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.000192	CcSEcCtD
Topiramate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000192	CcSEcCtD
Topiramate—Tachycardia—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000192	CcSEcCtD
Topiramate—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.57e-05	0.000191	CcSEcCtD
Topiramate—Skin disorder—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000191	CcSEcCtD
Topiramate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.55e-05	0.00019	CcSEcCtD
Topiramate—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.54e-05	0.000189	CcSEcCtD
Topiramate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.52e-05	0.000187	CcSEcCtD
Topiramate—Dizziness—Valsartan—type 2 diabetes mellitus	2.52e-05	0.000187	CcSEcCtD
Topiramate—Anorexia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000187	CcSEcCtD
Topiramate—Dizziness—Orlistat—type 2 diabetes mellitus	2.49e-05	0.000185	CcSEcCtD
Topiramate—Asthenia—Metformin—type 2 diabetes mellitus	2.49e-05	0.000185	CcSEcCtD
Topiramate—Hypotension—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000184	CcSEcCtD
Topiramate—Nausea—Gliclazide—type 2 diabetes mellitus	2.46e-05	0.000183	CcSEcCtD
Topiramate—Pruritus—Metformin—type 2 diabetes mellitus	2.45e-05	0.000182	CcSEcCtD
Topiramate—Urticaria—Losartan—type 2 diabetes mellitus	2.45e-05	0.000182	CcSEcCtD
Topiramate—Abdominal pain—Losartan—type 2 diabetes mellitus	2.43e-05	0.000181	CcSEcCtD
Topiramate—Body temperature increased—Losartan—type 2 diabetes mellitus	2.43e-05	0.000181	CcSEcCtD
Topiramate—Vomiting—Valsartan—type 2 diabetes mellitus	2.42e-05	0.00018	CcSEcCtD
Topiramate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.41e-05	0.000179	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000179	CcSEcCtD
Topiramate—Rash—Valsartan—type 2 diabetes mellitus	2.4e-05	0.000179	CcSEcCtD
Topiramate—Dermatitis—Valsartan—type 2 diabetes mellitus	2.4e-05	0.000178	CcSEcCtD
Topiramate—Vomiting—Orlistat—type 2 diabetes mellitus	2.39e-05	0.000178	CcSEcCtD
Topiramate—Insomnia—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000178	CcSEcCtD
Topiramate—Headache—Valsartan—type 2 diabetes mellitus	2.38e-05	0.000177	CcSEcCtD
Topiramate—Diarrhoea—Metformin—type 2 diabetes mellitus	2.37e-05	0.000176	CcSEcCtD
Topiramate—Rash—Orlistat—type 2 diabetes mellitus	2.37e-05	0.000176	CcSEcCtD
Topiramate—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000176	CcSEcCtD
Topiramate—Dermatitis—Orlistat—type 2 diabetes mellitus	2.37e-05	0.000176	CcSEcCtD
Topiramate—Headache—Orlistat—type 2 diabetes mellitus	2.36e-05	0.000175	CcSEcCtD
Topiramate—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000175	CcSEcCtD
Topiramate—Asthenia—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000175	CcSEcCtD
Topiramate—Somnolence—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000175	CcSEcCtD
Topiramate—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000173	CcSEcCtD
Topiramate—Pruritus—Irbesartan—type 2 diabetes mellitus	2.31e-05	0.000172	CcSEcCtD
Topiramate—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000171	CcSEcCtD
Topiramate—Dizziness—Metformin—type 2 diabetes mellitus	2.29e-05	0.000171	CcSEcCtD
Topiramate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.28e-05	0.00017	CcSEcCtD
Topiramate—Fatigue—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000169	CcSEcCtD
Topiramate—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.27e-05	0.000169	CcSEcCtD
Topiramate—Nausea—Valsartan—type 2 diabetes mellitus	2.26e-05	0.000168	CcSEcCtD
Topiramate—Constipation—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000168	CcSEcCtD
Topiramate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.24e-05	0.000167	CcSEcCtD
Topiramate—Nausea—Orlistat—type 2 diabetes mellitus	2.23e-05	0.000166	CcSEcCtD
Topiramate—Asthenia—Losartan—type 2 diabetes mellitus	2.21e-05	0.000164	CcSEcCtD
Topiramate—Vomiting—Metformin—type 2 diabetes mellitus	2.2e-05	0.000164	CcSEcCtD
Topiramate—Rash—Metformin—type 2 diabetes mellitus	2.19e-05	0.000163	CcSEcCtD
Topiramate—Dermatitis—Metformin—type 2 diabetes mellitus	2.18e-05	0.000162	CcSEcCtD
Topiramate—Pruritus—Losartan—type 2 diabetes mellitus	2.18e-05	0.000162	CcSEcCtD
Topiramate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000162	CcSEcCtD
Topiramate—Headache—Metformin—type 2 diabetes mellitus	2.17e-05	0.000162	CcSEcCtD
Topiramate—Dizziness—Irbesartan—type 2 diabetes mellitus	2.16e-05	0.000161	CcSEcCtD
Topiramate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000161	CcSEcCtD
Topiramate—Diarrhoea—Losartan—type 2 diabetes mellitus	2.11e-05	0.000157	CcSEcCtD
Topiramate—Urticaria—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000156	CcSEcCtD
Topiramate—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.09e-05	0.000155	CcSEcCtD
Topiramate—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.09e-05	0.000155	CcSEcCtD
Topiramate—Vomiting—Irbesartan—type 2 diabetes mellitus	2.08e-05	0.000155	CcSEcCtD
Topiramate—Rash—Irbesartan—type 2 diabetes mellitus	2.06e-05	0.000153	CcSEcCtD
Topiramate—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.06e-05	0.000153	CcSEcCtD
Topiramate—Nausea—Metformin—type 2 diabetes mellitus	2.06e-05	0.000153	CcSEcCtD
Topiramate—Headache—Irbesartan—type 2 diabetes mellitus	2.05e-05	0.000152	CcSEcCtD
Topiramate—Dizziness—Losartan—type 2 diabetes mellitus	2.04e-05	0.000151	CcSEcCtD
Topiramate—Vomiting—Losartan—type 2 diabetes mellitus	1.96e-05	0.000146	CcSEcCtD
Topiramate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.95e-05	0.000145	CcSEcCtD
Topiramate—Nausea—Irbesartan—type 2 diabetes mellitus	1.94e-05	0.000145	CcSEcCtD
Topiramate—Rash—Losartan—type 2 diabetes mellitus	1.94e-05	0.000144	CcSEcCtD
Topiramate—Dermatitis—Losartan—type 2 diabetes mellitus	1.94e-05	0.000144	CcSEcCtD
Topiramate—Headache—Losartan—type 2 diabetes mellitus	1.93e-05	0.000144	CcSEcCtD
Topiramate—Asthenia—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000141	CcSEcCtD
Topiramate—Pruritus—Ramipril—type 2 diabetes mellitus	1.87e-05	0.000139	CcSEcCtD
Topiramate—Nausea—Losartan—type 2 diabetes mellitus	1.83e-05	0.000136	CcSEcCtD
Topiramate—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.81e-05	0.000134	CcSEcCtD
Topiramate—Dizziness—Ramipril—type 2 diabetes mellitus	1.75e-05	0.00013	CcSEcCtD
Topiramate—Vomiting—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000125	CcSEcCtD
Topiramate—Rash—Ramipril—type 2 diabetes mellitus	1.66e-05	0.000124	CcSEcCtD
Topiramate—Dermatitis—Ramipril—type 2 diabetes mellitus	1.66e-05	0.000124	CcSEcCtD
Topiramate—Headache—Ramipril—type 2 diabetes mellitus	1.65e-05	0.000123	CcSEcCtD
Topiramate—Nausea—Ramipril—type 2 diabetes mellitus	1.57e-05	0.000117	CcSEcCtD
Topiramate—CA2—Metabolism—AGT—type 2 diabetes mellitus	5.71e-06	8.15e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AK1—type 2 diabetes mellitus	5.66e-06	8.08e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARA—type 2 diabetes mellitus	5.65e-06	8.07e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	5.64e-06	8.06e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—LPL—type 2 diabetes mellitus	5.63e-06	8.03e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CALM1—type 2 diabetes mellitus	5.61e-06	8.02e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—type 2 diabetes mellitus	5.59e-06	7.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	5.59e-06	7.98e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	5.56e-06	7.95e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOA1—type 2 diabetes mellitus	5.53e-06	7.9e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	5.51e-06	7.86e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GPX1—type 2 diabetes mellitus	5.49e-06	7.84e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	5.48e-06	7.83e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—NOS3—type 2 diabetes mellitus	5.48e-06	7.83e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AGT—type 2 diabetes mellitus	5.47e-06	7.82e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	5.43e-06	7.76e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.42e-06	7.74e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	5.41e-06	7.73e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	5.41e-06	7.73e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CALM1—type 2 diabetes mellitus	5.38e-06	7.69e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.37e-06	7.67e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—type 2 diabetes mellitus	5.36e-06	7.66e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CD36—type 2 diabetes mellitus	5.35e-06	7.63e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOA1—type 2 diabetes mellitus	5.3e-06	7.57e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	5.29e-06	7.55e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.28e-06	7.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A4—type 2 diabetes mellitus	5.22e-06	7.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MAT1A—type 2 diabetes mellitus	5.22e-06	7.45e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—type 2 diabetes mellitus	5.21e-06	7.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	5.2e-06	7.42e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	5.13e-06	7.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	5.1e-06	7.28e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—type 2 diabetes mellitus	5.08e-06	7.26e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	5.07e-06	7.23e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	5.06e-06	7.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	5.04e-06	7.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	5.04e-06	7.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	5.04e-06	7.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	5.04e-06	7.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.04e-06	7.2e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	5.01e-06	7.16e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—INS—type 2 diabetes mellitus	4.99e-06	7.12e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARA—type 2 diabetes mellitus	4.97e-06	7.1e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.91e-06	7.02e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	4.88e-06	6.97e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—type 2 diabetes mellitus	4.87e-06	6.96e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.86e-06	6.93e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AGT—type 2 diabetes mellitus	4.81e-06	6.87e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.8e-06	6.86e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—INS—type 2 diabetes mellitus	4.78e-06	6.82e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	4.76e-06	6.8e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CALM1—type 2 diabetes mellitus	4.73e-06	6.76e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—type 2 diabetes mellitus	4.72e-06	6.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	4.7e-06	6.71e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—type 2 diabetes mellitus	4.67e-06	6.67e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOA1—type 2 diabetes mellitus	4.66e-06	6.66e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	4.61e-06	6.58e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	4.61e-06	6.58e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—INS—type 2 diabetes mellitus	4.58e-06	6.54e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—type 2 diabetes mellitus	4.57e-06	6.53e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	4.53e-06	6.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	4.49e-06	6.42e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—type 2 diabetes mellitus	4.38e-06	6.26e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.37e-06	6.24e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—type 2 diabetes mellitus	4.37e-06	6.24e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	4.3e-06	6.14e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.3e-06	6.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	4.29e-06	6.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	4.29e-06	6.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	4.29e-06	6.12e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—type 2 diabetes mellitus	4.2e-06	6e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.19e-06	5.98e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—type 2 diabetes mellitus	4.19e-06	5.98e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	4.11e-06	5.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	4.11e-06	5.87e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—type 2 diabetes mellitus	4.11e-06	5.86e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—INS—type 2 diabetes mellitus	4.03e-06	5.75e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—type 2 diabetes mellitus	4.02e-06	5.74e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.02e-06	5.74e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	4e-06	5.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	3.96e-06	5.65e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	3.96e-06	5.65e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	3.89e-06	5.55e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.88e-06	5.55e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	3.83e-06	5.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	3.82e-06	5.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	3.82e-06	5.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	3.82e-06	5.46e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	3.76e-06	5.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	3.76e-06	5.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.7e-06	5.29e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—type 2 diabetes mellitus	3.69e-06	5.27e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	3.68e-06	5.25e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	3.66e-06	5.23e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	3.59e-06	5.13e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	3.57e-06	5.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	3.57e-06	5.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.54e-06	5.05e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—type 2 diabetes mellitus	3.53e-06	5.04e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.53e-06	5.04e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.45e-06	4.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	3.4e-06	4.86e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	3.38e-06	4.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	3.36e-06	4.8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.36e-06	4.8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	3.25e-06	4.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	3.25e-06	4.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	3.25e-06	4.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	3.25e-06	4.64e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	3.23e-06	4.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	3.14e-06	4.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	3.14e-06	4.48e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.12e-06	4.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	3.11e-06	4.45e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	3.03e-06	4.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	3.03e-06	4.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.03e-06	4.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	3.03e-06	4.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	3.03e-06	4.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.03e-06	4.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.96e-06	4.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	2.94e-06	4.19e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.93e-06	4.18e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	2.91e-06	4.16e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—type 2 diabetes mellitus	2.91e-06	4.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	2.9e-06	4.13e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	2.77e-06	3.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	2.77e-06	3.96e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-06	3.88e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-06	3.88e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	2.7e-06	3.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	2.7e-06	3.86e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	2.65e-06	3.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	2.65e-06	3.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	2.6e-06	3.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.58e-06	3.69e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	2.58e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	2.58e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	2.58e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	2.58e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	2.58e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	2.58e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	2.56e-06	3.66e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—type 2 diabetes mellitus	2.52e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	2.52e-06	3.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	2.49e-06	3.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	2.47e-06	3.53e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.47e-06	3.53e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.38e-06	3.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.38e-06	3.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.34e-06	3.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.32e-06	3.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	2.31e-06	3.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	2.31e-06	3.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	2.31e-06	3.31e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.3e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.3e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.3e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	2.27e-06	3.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	2.25e-06	3.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.22e-06	3.17e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	2.2e-06	3.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.16e-06	3.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	2.12e-06	3.02e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	2.09e-06	2.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	2.09e-06	2.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	2.04e-06	2.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.03e-06	2.9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.02e-06	2.89e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—type 2 diabetes mellitus	2.01e-06	2.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	2.01e-06	2.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	2.01e-06	2.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.95e-06	2.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.95e-06	2.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.95e-06	2.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.95e-06	2.79e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—type 2 diabetes mellitus	1.93e-06	2.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.87e-06	2.67e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—type 2 diabetes mellitus	1.85e-06	2.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.74e-06	2.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.73e-06	2.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.73e-06	2.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.72e-06	2.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.7e-06	2.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.65e-06	2.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.63e-06	2.32e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.6e-06	2.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.59e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.59e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.57e-06	2.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.56e-06	2.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.55e-06	2.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.55e-06	2.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.55e-06	2.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.54e-06	2.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.54e-06	2.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.54e-06	2.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.51e-06	2.16e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.5e-06	2.14e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.5e-06	2.14e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.48e-06	2.11e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.42e-06	2.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.39e-06	1.99e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.39e-06	1.99e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.39e-06	1.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.39e-06	1.99e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.37e-06	1.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.35e-06	1.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.35e-06	1.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.33e-06	1.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.32e-06	1.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.32e-06	1.88e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.3e-06	1.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.27e-06	1.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.26e-06	1.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.26e-06	1.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.21e-06	1.72e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.21e-06	1.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.15e-06	1.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.13e-06	1.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.04e-06	1.49e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.04e-06	1.49e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.04e-06	1.48e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.03e-06	1.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.02e-06	1.46e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.92e-07	1.42e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	9.89e-07	1.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	9.89e-07	1.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.65e-07	1.38e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.47e-07	1.35e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.27e-07	1.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.24e-07	1.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	9.05e-07	1.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9e-07	1.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.89e-07	1.27e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.53e-07	1.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.37e-07	1.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.1e-07	1.16e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.97e-07	1.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.94e-07	1.13e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.85e-07	1.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.91e-07	9.87e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.78e-07	9.68e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.22e-07	8.88e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.95e-07	8.49e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.95e-07	8.49e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.44e-07	7.77e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	4.55e-07	6.49e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.73e-07	3.9e-06	CbGpPWpGaD
